Patent Number: 6,251,590

Title: Differential Qualitative screening

Abstract: The present invention is directed to a method for identifying and/or cloning within a biological sample alternatively spliced nucleic acid regions ocurring between two physiological conditions, comprising hybridizing RNA derived from a test condition with cDNA derived from the standard condition and further identifying and/or cloning nucleic acids corresponding to alternative forms of splicing.

Inventors: Schweighoffer; Fabien (Vincennes, FR), Bracco; Laurent (Paris, FR), Tocque; Bruno (Courbevoie, FR)

Assignee: ExonHit Therapeutics S.A.

International Classification: C12Q 1/68 (20060101); C12Q 001/68 (); C12P 019/34 (); C07H 021/02 (); C07H 021/04 ()

Expiration Date: 06/26/2018